FDA Recommends DEA Move Cannabis to Schedule III FDA Recommends DEA Move Cannabis to Schedule III

Newly released documents show that the FDA has determined that cannabis has legitimate medical use and that it should be moved from Schedule I to Schedule III on the controlled substances list.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Psychiatry Source Type: news